{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-050406","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2025-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.393037+00:00","generated_at":"2026-05-23T22:29:19.492670+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Arcadia Biosciences enters agreement to receive $750,000 and transfer certain patent assets","bullets":["A third party agreed to pay Arcadia $750,000 as part of the agreement.","The third party transferred back to Arcadia all rights and materials related to certain intellectual property and traits previously licensed.","Arcadia transferred its reduced gluten and oxidative stability granted patents and pending applications to the third party.","The parties amended a prior agreement to eliminate any future product royalty obligations payable to Arcadia."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-050406","json":"https://secwatch.observer/filing/0000950170-25-050406.json","markdown":"https://secwatch.observer/filing/0000950170-25-050406.md","text":"https://secwatch.observer/filing/0000950170-25-050406.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017025050406/0000950170-25-050406-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017025050406/rkda-20250328.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-23T22:29:19.492670+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}